期刊文献+

EMS1蛋白在喉癌组织中的表达及临床意义 被引量:1

Expression of EMS1 protein and its clinical significance in laryngeal carcinoma
原文传递
导出
摘要 目的:探讨EMS1在喉癌组织中的表达及与各临床病理因素的关系。方法:采用流式细胞术检测40例喉癌组织和40例相应癌旁组织中EMS1的表达,并以20例非喉癌患者喉部正常黏膜组织作对照。结果:喉癌组织中EMS1蛋白的表达量及阳性表达率均明显高于癌旁组织及正常喉黏膜组织(P<0.05),癌旁组织及正常喉黏膜组织间的EMS1表达差异无统计学意义(P>0.05)。EMS1蛋白的表达与喉癌组织中的淋巴结转移、临床分期、分化程度差异有统计学意义(P<0.05);与临床分型、肿瘤大小、吸烟量、年龄和性别差异无统计学意义(P>0.05)。结论:EMS1蛋白的高表达可促进喉癌的发生、发展,其蛋白检测可作为判断喉癌分化、浸润、转移、分期的重要指标。 Objective: To investigate the expression of EMS1 in laryngeal carcinoma and its clinical significance. Method:The expression of EMS1 protein was measured in 40 samples of,40 samples of para carcinoma tissues(which were near to cutting margin of laryngeal carcinoma tissuse over 0.5 cm) ,and 20 samples of normal laryngeal mucosa as controls by Flow Cytometere(Epics XL Ⅱ). Result:The quantity and percentage of EMS1 protein expression in laryngeal carcinoma tissues was significantly higher than those in para carcinoma and in normal laryngeal mucosa tissues respectively(P〈0.05). There was no significant expression difference between the para carcinoma tissues and normal laryngeal mucosa tissues. There were positive correlation between the expressions of EMS1 protein and metastasis, pathological grade and clinical stage in laryngeal carcinoma. But there were not relationship with patients' clinical classification, tumor size, smoking history, age and sex. Conclusion: The high expression of EMS1 may contribute to the carcinogenesis and development of laryngeal carcinoma. The expression of EMS1 protein is an important index of judging differentiation, infiltration, metastasis and staging of laryngeal carcinoma.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2009年第15期673-675,共3页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
关键词 喉肿瘤 EMS1蛋白 流式细胞术 laryngeal neoplasms EMS1 protein flow cytometry
  • 相关文献

参考文献1

二级参考文献10

  • 1Ishizuka T, Tanabe C, Sakamoto H, et al. Gene amplification profiling of esophageal squamous cell carcinomas by DNA array CGH. Biochem Biophys Res Commun 2002; 296:152-155.
  • 2Wei F, Ni J, Wu sS, et al. Cytogenetic studies of esophageal squamous cell carcinomas in the northern Chinese population by comparative genomic hybridization. Cancer Genet Cytogenet 2002; 138:38-43.
  • 3Luo ML, Shen XM, Zhang Y, et al. Amplification and overexpression ofCTTN (EMS 1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. Cancer Res 2006; 66:11690-11699.
  • 4Daly RJ. Cortactin signalling and dynamic actin networks. Biochem J 2004; 382 (Pt 1): 13-25.
  • 5Bowden ET, Barth M, Thomas D, Glazer RI, Mueller SC. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene 1999; 18:4440-4449.
  • 6Zhu Z, Sanchez-Sweatman O, Huang X, et al. Anoikis and metastatic potential of cloudman S91 melanoma cells. Cancer Res 2001; 61:1707-1716.
  • 7Chuma M, Sakamoto M, Yasuda J, et al. Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. J Hepatol 2004; 41:629-636.
  • 8lRothschild BL, Shim AH, Ammer AG, et aL Cortactin overexpression regulates actin-related protein 2/3 complex activity,motility, and invasion in carcinomas with chromosome 11q13 amplification. Cancer Res 2006; 66:8017-8025.
  • 9Frisch SM, Screaton RA. Anoikis mechanisms. Curr Opin Cell Biol 2001; 13:555-562.
  • 10Reginato M J, Mills KR, Paulus JK, et al. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat Cell Biol 2003; 5:733-740.

共引文献2

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部